News

Initial public offerings scheduled to debut next week

NEW YORK, N.Y. – The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of July 13:

BioCardia Inc. – San Carlos, Calif., 3.8 million shares, priced $12 to $14, managed by Cantor Fitzgerald. Proposed Nasdaq symbol BCDA. Business: Clinical-stage regenerative medicine company developing therapeutics for cardiovascular diseases with large unmet medical needs.

Chiasma Inc. – Newton, Mass., 5.4 million shares, priced $13 to $15, managed by Barclays, and Cowen & Co. Proposed Nasdaq symbol CHMA. Business: Late-stage biotech developing an oral drug candidate for acromegaly.

Jupai Holdings Ltd. – Shanghai, China, 5.866 million American depositary shares, each representing 6 ordinary shares, priced $10 to $12, managed by Credit Suisse, and China Renaissance. Proposed NYSE symbol JP. Business: Provider of wealth management products.

MCBC Holdings Inc. – Vonore, Tenn., 6.1 million shares, priced $13 to $15, managed by Baird, Raymond James, and Wells Fargo. Proposed Nasdaq symbol MCFT. Business: Manufacturer of MasterCraft sport boats.

Ollie’s Bargain Outlet Holdings Inc. – Harrisburg, Pa., 8.925 million shares, priced $13 to $15, managed by J.P. Morgan, Jefferies, and BofA Merrill Lynch. Proposed Nasdaq symbol OLLI. Business: Retailer of brand name merchandise at reduced prices.

Ooma Inc. – Palo Alto, Calif., 5 million shares, priced $16 to $18, managed by Credit Suisse, BofA Merrill Lynch, and JMP Securities. Proposed NYSE symbol OOMA. Business: Provides internet-based telecom services for homes and small businesses.

ProNAi Therapeutics Inc. – Vancouver, B.C., Canada, 6.7 million shares, priced $14 to $16, managed by Jefferies, and Merrill Lynch. Proposed Nasdaq symbol DNAI. Business: Clinical-stage oncology company developing a class of therapeutics based on a proprietary DNA interference (DNAi) technology platform.

Rapid7 Inc. – Boston, 6.5 million shares, priced $13 to $15, managed by Morgan Stanley, and Barclays. Proposed Nasdaq symbol RPD. Business: Provides enterprise network security software.